About COI

Conflict of Interest (COI) Declaration & Disclosure

The Japanese Society for Dialysis Therapy has implemented the guidelines on conflicts of interest since 20th April 2015. The regulations require a first author of an abstract of an annual meeting to submit a self-declaration form if a conflict of interest relevant to the abstract exists, and to disclose the COI on the day of presentation.

Persons who need to declare /
disclose a conflict of interest

All first authors of abstracts to be presented in an annual meeting (including speakers from overseas, speakers of luncheon seminars)

Time period to be covered by declaration / disclosure

Last 3 years (From 1st January, 2021 to 31st December 2023)

How to determine an existence of a conflict of interest

If the content of a presentation is related to a corporate profit, and an author of the presentation has received any economic benefits from the company as far back as 1 (one) year before the date of an abstract submission, this presentation / abstract is judged to have a conflict of interest. The author of such a presentation / abstract is required to submit a COI self-declaration form.

Disclosure of a conflict of interest

On the day of presentation, all speakers are asked to include in their presentations a disclosure statement regarding the existence of any conflict of interest, and name(s) of company / companies, if any conflict of interest exists.

Oral presenters: Please add a disclosure statement in the second page of presentation slide. Poster presenters: Please write a disclosure statement in the last part of the poster.

Q&A

• Who needs to declare conflicts of interest?
  All presenting authors of an annual meeting of the Japanese Society for Dialysis Therapy.
• Do all the authors of an abstract need to declare conflicts of interest?
  Only presenting authors need to make a declaration. Co-authors do not need.

• What must be declared as a conflict of interest?
  Under the Society's guidelines, a conflict of interest exists when a presenter

  1. is appointed as a board member or an adviser, or starts working as an employee of a company, legal entity, or commercial organization,

  2. has stock in a company,

  3. receives patent royalty from a company, legal entity, or commercial organization,

  4. receives from a company, legal entity, or commercial organization, a per diem (including lecture fee) for participating in a meeting, delivering a presentation or lecture in a meeting, or appearing in the media,

  5. receives from a company, legal entity, or commercial organization, fee for writing, editing, or overseeing the writing of a leaflet or a production of video,

  6. receives expenses for medical researches (including clinical trials) provided by a company, legal entity, or commercial organization,

  7. receives research expenses (including funded research, collaborative research, donation) provided by a company, legal entity, or commercial organization,

  8. is appointed as a chair of a course endowed by a company, legal entity, or commercial organization,

  9. receives other travel expenses (for participation in a conference) or gifts.

• What time period is covered by declaration / disclosure?
  Last 3 years (From 1st January, 2021 to 31st December 2023)
• Is the amount to be declared the sum total of whole three years? Or to be declared annually?
  Annually.
• Could donations to an institution or organization to which authors belong be a conflict of interest?
  Yes, it is the item to be declared / disclosed.

Sample Slides